Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharmaâ??s lead product candidate, OC-01, a highly selective nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. Dry eye disease is a chronic, progressive condition that impacts more than 30 million Americans and is growing in prevalence. OC-01â??s novel mechanism of action re-establishes tear film homeostasis by activating the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the Lacrimal Functional Unit (LFU).
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Oyster Point Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Oyster Point Pharma Inc market cap is $299.85M.
What is the 52-week high for Oyster Point Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oyster Point Pharma Inc 52 week high is $16.61 as of September 06, 2025.
What is the 52-week low for Oyster Point Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oyster Point Pharma Inc 52 week low is $3.46 as of September 06, 2025.
What is Oyster Point Pharma Inc stock price today?
Oyster Point Pharma Inc stock price today is $11.17.
What was Oyster Point Pharma Inc stock price yesterday?
Oyster Point Pharma Inc stock price yesterday was $11.15.
What is the PE ratio of Oyster Point Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Oyster Point Pharma Inc’s P/E ratio is -1.68.
What is the Price-to-Book ratio of Oyster Point Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Oyster Point Pharma Inc P/B ratio is -13.4991.
What is the 50-day moving average of Oyster Point Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Oyster Point Pharma Inc 50-day moving average is $10.49.